Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early vascular endothelial complications after hematopoietic cell transplantation: Role of the endotheliopathy in biomarkers and target therapies development.
Moreno-Castaño AB, Salas MQ, Palomo M, Martinez-Sanchez J, Rovira M, Fernández-Avilés F, Martínez C, Cid J, Castro P, Escolar G, Carreras E, Diaz-Ricart M. Moreno-Castaño AB, et al. Among authors: salas mq. Front Immunol. 2022 Nov 21;13:1050994. doi: 10.3389/fimmu.2022.1050994. eCollection 2022. Front Immunol. 2022. PMID: 36479117 Free PMC article. Review.
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation.
Salas MQ, Atenafu EG, Law AD, Lam W, Pasic I, Chen C, Dong Hwan Kim D, Michelis FV, Gerbitz A, Lipton JH, Mattsson J, Kumar R, Viswabandya A. Salas MQ, et al. Transplant Cell Ther. 2021 May;27(5):428.e1-428.e9. doi: 10.1016/j.jtct.2021.02.007. Epub 2021 Feb 13. Transplant Cell Ther. 2021. PMID: 33965185 Free article.
Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study.
Carreira AS, Salas MQ, Remberger M, Basso IN, Law AD, Lam W, Pasic I, Kim D, Michelis FV, Viswabandya A, Gerbitz A, Lipton JH, Husain S, Kumar R, Mattsson J. Carreira AS, et al. Among authors: salas mq. Transplant Cell Ther. 2022 Jan;28(1):50.e1-50.e8. doi: 10.1016/j.jtct.2021.10.008. Epub 2021 Oct 14. Transplant Cell Ther. 2022. PMID: 34656808 Free article.
PTCY and Tacrolimus for GVHD Prevention for Older Adults Undergoing HLA-Matched Sibling and Unrelated Donor AlloHCT.
Salas MQ, Charry P, Pedraza A, Martínez-Cibrian N, Solano MT, Domènech A, Suárez-Lledó M, Nomdedeu M, Cid J, Lozano M, de-LLobet N, Arcarons J, Rosiñol L, Gutiérrez-García G, Carreras E, Esteve J, Urbano-Ispizua Á, Fernández-Avilés F, Rovira M, Martínez C. Salas MQ, et al. Transplant Cell Ther. 2022 Aug;28(8):489.e1-489.e9. doi: 10.1016/j.jtct.2022.05.009. Epub 2022 May 14. Transplant Cell Ther. 2022. PMID: 35577323 Free article.
Bacterial Bloodstream Infections in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide.
Salas MQ, Charry P, Puerta-Alcalde P, Martínez-Cibrian N, Solano MT, Serrahima A, Nomdedeu M, Cid J, Lozano M, Chumbinta M, Aiello TF, Arcarons J, LLobet N, Pedraza A, Rosiñol L, Esteve J, Urbano-Ispizua Á, Carreras E, Martínez C, Fernández-Avilés F, García-Vidal C, Suárez-Lledó M, Rovira M. Salas MQ, et al. Transplant Cell Ther. 2022 Dec;28(12):850.e1-850.e10. doi: 10.1016/j.jtct.2022.09.001. Epub 2022 Sep 9. Transplant Cell Ther. 2022. PMID: 36089250 Free article.
Hyponatremia induced by post-transplant cyclophosphamide in allogeneic hematopoietic cell transplantation.
Gómez-Hernando M, Quintana LF, Suárez-Lledo M, Martínez-Cibrian N, Rivero A, Ruiz-Boy S, Carcelero E, Mate P, Riu G, Monge I, Serrahima A, Solano MT, Rosiñol L, Esteve J, Urbano-Ispizua A, Carreras E, Fernández-Avilés F, Martínez C, Rovira M, Salas MQ. Gómez-Hernando M, et al. Among authors: salas mq. Bone Marrow Transplant. 2023 Feb;58(2):212-214. doi: 10.1038/s41409-022-01864-7. Epub 2022 Nov 5. Bone Marrow Transplant. 2023. PMID: 36335256 No abstract available.
Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant.
Pérez-Valencia AI, Cascos E, Carbonell-Ordeig S, Charry P, Gómez-Hernando M, Rodríguez-Lobato LG, Suárez-Lledó M, Martínez-Cibrian N, Antelo MG, Solano MT, Arcarons J, Nomdedeu M, Cid J, Lozano M, Díaz-Ricart M, Rosiñol L, Esteve J, Urbano-Ispizua Á, Carreras E, Martínez C, Fernández-Avilés F, Rovira M, Salas MQ. Pérez-Valencia AI, et al. Among authors: salas mq. Blood Adv. 2023 May 23;7(10):2018-2031. doi: 10.1182/bloodadvances.2022008792. Blood Adv. 2023. PMID: 36453637 Free PMC article.
Effect of CD34+ Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide.
Pedraza A, Salas MQ, Rodríguez-Lobato LG, Charry P, Suárez-Lledo M, Martínez-Cibrian N, Doménech A, Solano MT, Arcarons J, de Llobet N, Rosiñol L, Gutiérrez-García G, Avilés FF, Urbano-Ispízua Á, Rovira M, Martínez C. Pedraza A, et al. Among authors: salas mq. Transplant Cell Ther. 2023 Mar;29(3):181.e1-181.e10. doi: 10.1016/j.jtct.2022.12.005. Epub 2022 Dec 14. Transplant Cell Ther. 2023. PMID: 36526259 Free article.
59 results